Cartrophen Vet: The disease modifying osteoarthritis drug longest on the market

osteoarthritis treatment for dogs

This article is sponsored content brought to you by Biopharm Australia.

Exciting News

Biopharm Australia pioneered the veterinary development of sodium pentosan polysulfate as a disease modifying osteoarthritis drug (DMOAD) under the well-known name CARTROPHEN VET.

We are a world leader in osteoarthritis treatment with high standard of safety and efficacy. Our products are acknowledged internationally, being approved as veterinary medicines by regulatory authorities around the world in more than 22 countries, where other disease modifying osteoarthritis drug have failed to obtain registration.

What’s New

Biopharm heavily invests in the development of new technologies and employee training. Recently three of members of staff Íde Kennedy, Conor Nolan and Vivek Bewley completed a course in Pharmaceutical and Medical Devices. David Cullis-Hill, the Managing Director, also completed a Masters in pharmaceutical manufacturing technology.

New Facility

Recently we build a state of the art microbiological testing facility. This will allow us to perform all microbiological tests involved in the manufacturing of CVI and CEF in house. This will mean a faster turnaround time and a greater reliability on the results. Some of the tests we will be carrying out are Total Aerobic Microbial Counts, Total Yeast & Mould Counts, Pharmaceutical Waters, Bioburden Integrity Testing and Sterility Testing. The testing will be conducted according to British, European and US pharmacopoeias.

For more information 

Call: 02 9389 0000

Email: or or visit

Visit Biopharm Australia.

Vet Practice magazine and its associated website is published by Engage Media. All material is protected by copyright and may not be reproduced in any form without prior written permission. Explore how our content marketing agency can help grow your business at Engage Content or at

Post a Comment

Your email address will not be published. Required fields are marked *

Subscribe to our newsletter

Want stories like this delivered to your inbox? FOR FREE!
Give it a try, you can unsubscribe anytime.